iTechDachs:
Und ein kurzer Artikel dazu
19.11.18 14:48
Marlborough startup drugmaker RXI Pharmaceuticals now has a runway extending into 2020 as the company continues to reinvent itself and rebrand into a pharmaceutical firm focused on fighting cancer.
Xtrackers MSCI Korea UCITS ETF 1C
Perf. 12M: +219,70%
Xtrackers MSCI Taiwan UCITS ETF 1D
Perf. 12M: +100,82%
Xtrackers MSCI Taiwan UCITS ETF 1C
Perf. 12M: +99,24%
Xtrackers MSCI Gbl SDG 7 Affor. and Clean Ener. UCITS ETF 1C
Perf. 12M: +80,45%
Xtrackers CSI500 Swap UCITS ETF 1C
Perf. 12M: +73,37%